awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
SJ.BJC.6605886
SJ.BJC.6605886
http://dx.doi.org/10.1038/SJ.BJC.6605886
Comment on 'costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib'.
P356
Q42392542-DCB58555-1471-4414-B739-7A7D2B883CC0
P356
SJ.BJC.6605886
http://dx.doi.org/10.1038/SJ.BJC.6605886